During the past decade, The Second Hospital of Shandong University conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 1 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Hospital of Shandong University" #1 sponsor was "The Second Hospital of Shandong University" with 12 trials, followed by "First Hospital of China Medical University" with 2 trials sponsored, "Peking Union Medical College Hospital" with 2 trials sponsored, "Qilu Hospital of Shandong University" with 2 trials sponsored and "Shandong University" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Hospital of Shandong University" #1 collaborator was "The Second Hospital of Shandong University" with 5 trials as a collaborator, "Ruijin Hospital" with 2 trials as a collaborator, "The General Hospital of Fushun Mining Bureau" with 2 trials as a collaborator, "The fourth People's Hospital of Changzhou" with 2 trials as a collaborator and "Anhui Provincial Hospital" with 1 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "The Second Hospital of Shandong University" are "Alzheimer Disease" (2 trials), "Chronic Heart Failure" (2 trials), "Lung Diseases" (2 trials), "Stomach Neoplasms" (2 trials) and "Stroke" (2 trials). Many other conditions were trialed in "The Second Hospital of Shandong University" in a lesser frequency.

Most popular intervention types in "The Second Hospital of Shandong University" are "Drug" (18 trials), "Procedure" (9 trials), "Other" (4 trials), "Biological" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Allogeneic NK cell regimen group" (2 trials), "placebo" (2 trials), "rhNRG-1" (2 trials) and "3D simulation Guided Anatomic Segmentectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Second Hospital of Shandong University" are 35 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 17 active trials in "The Second Hospital of Shandong University". 2 are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in The Second Hospital of Shandong University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Hospital of Shandong University, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 11 trials that are defined as “Not Applicable".